These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27192525)

  • 1. Paronychia and granulation tissue formation during treatment with isotretinoin.
    Figueiras Dde A; Ramos TB; Marinho AK; Bezerra MS; Cauas RC
    An Bras Dermatol; 2016 Apr; 91(2):223-5. PubMed ID: 27192525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paronychia and the formation of granulation tissue during isotretinoin therapy].
    De Raeve L; Willemsen M; De Coninck A; Roseeuw D
    Dermatologica; 1986; 172(5):278-80. PubMed ID: 2943615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case reports: mitozantrone-induced onycholysis associated with subungual abscesses, paronychia, and pyogenic granuloma.
    Freiman A; Bouganim N; O'Brien EA
    J Drugs Dermatol; 2005; 4(4):490-2. PubMed ID: 16004024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe ulcerated 'bodybuilding acne' caused by anabolic steroid use and exacerbated by isotretinoin.
    Voelcker V; Sticherling M; Bauerschmitz J
    Int Wound J; 2010 Jun; 7(3):199-201. PubMed ID: 20602651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyogenic granuloma-like lesions in a patient using topical tretinoin.
    MacKenzie-Wood AR; Wood G
    Australas J Dermatol; 1998 Nov; 39(4):248-50. PubMed ID: 9838723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulation tissue proliferation during isotretinoin treatment.
    Puig L; Moreno A; Llistosella E; Noguera X; de Moragas JM
    Int J Dermatol; 1986 Apr; 25(3):191-3. PubMed ID: 2939033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare side-effect of systemic isotretinoin treatment: pyogenic granuloma.
    Türel A; Oztürkcan S; Sahin MT; Türkdogan P
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):609-11. PubMed ID: 12941114
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertrophic granulation tissue as a complication to isotretinoin treatment].
    Rødland O; Helland S
    Tidsskr Nor Laegeforen; 1991 Sep; 111(21):2630-1. PubMed ID: 1835182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyogenic granuloma association with isotretinoin treatment for acne.
    Simmons BJ; Chen L; Hu S
    Australas J Dermatol; 2016 Nov; 57(4):e144-e145. PubMed ID: 27885661
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Periungual Pyogenic Granuloma with Associated Paronychia Following Isotretinoin Therapy: A Case Report and a Review of the Literature.
    Benedetto C; Crasto D; Ettefagh L; Nami N
    J Clin Aesthet Dermatol; 2019 Apr; 12(4):32-36. PubMed ID: 31119008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid therapy is associated with excess granulation tissue responses.
    Campbell JP; Grekin RC; Ellis CN; Matsuda-John SS; Swanson NA; Voorhees JJ
    J Am Acad Dermatol; 1983 Nov; 9(5):708-13. PubMed ID: 6227639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin-induced acne fulminans without systemic symptoms with concurrent exuberant granulation tissue.
    Li AW; Antaya RJ
    Pediatr Dermatol; 2018 Mar; 35(2):257-258. PubMed ID: 29314240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aggravation of acne by isotretinoin. 6 cases, predictive factors].
    Lehucher Ceyrac D; Chaspoux C; Sulimovic L; Morel P; Lefrancq H
    Ann Dermatol Venereol; 1998 Aug; 125(8):496-9. PubMed ID: 9747314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors.
    Yen CF; Hsu CK; Lu CW
    J Am Acad Dermatol; 2018 Jun; 78(6):e143-e144. PubMed ID: 29339238
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study.
    Yen CF; Hsu CK; Yang HS; Lee CN; Chi CC; Chung WH; Wang CL; Pang JS; Wang CW; Ko YS; Lu CW
    Int J Dermatol; 2020 Mar; 59(3):326-332. PubMed ID: 31763692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular cystic acne: excessive granulation tissue caused by isotretinoin].
    Henkes J; Ferrandiz C; Ribera M; Servitje O; Peyri J
    Med Cutan Ibero Lat Am; 1987; 15(1):55-8. PubMed ID: 2955178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial pyogenic granuloma-like lesions under isotretinoin therapy.
    Hagler J; Hodak E; David M; Sandbank M
    Int J Dermatol; 1992 Mar; 31(3):199-200. PubMed ID: 1533205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpetic whitlow during isotretinoin therapy.
    Stetson CL; Butler DF; Rapini RP
    Int J Dermatol; 2003 Jun; 42(6):496-8. PubMed ID: 12786884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin-induced transverse leuconychia.
    Gregoriou S; Banaka F; Rigopoulos D
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):385-6. PubMed ID: 25354039
    [No Abstract]   [Full Text] [Related]  

  • 20. Isotretinoin-induced nail fragility and onycholysis.
    Onder M; Oztaş MO; Oztaş P
    J Dermatolog Treat; 2001 Jun; 12(2):115-6. PubMed ID: 12243670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.